All tests

Identification of pathogenic bacteria, such as Staphylococcus aureus (including MRSA), viruses

A blood test for expectant mothers, performed from 10 weeks of pregnancy, that screens for common fetal chromosomal conditions like Down’s Syndrome (T21), Edward’s Syndrome (T18), and Patau’s Syndrome (T13)

It is used as a tumour marker for certain cancers, especially neuroendocrine tumours like small-cell lung carcinoma and neuroblastoma

In patients with suspected worm infestations or intestinal parasites

Monitoring of cycle, fertility, menopause, hormone therapy

Confirmation and monitoring of pregnancy, diagnosis of ectopic pregnancy, assessment of miscarriage risk

Omega-3s (EPA, DHA): Anti-inflammatory, vital for brain, heart, and eye health. Omega-6s (like Arachidonic Acid - ARA): Necessary for energy and cell function, but too much (common in Western diets) promotes inflammation. Omega-3:6 Ratio: A key indicator; an imbalanced ratio (too many Omega-6s) can increase chronic inflammation and health risks. Omega-3 Index: Shows long-term intake by measuring Omega-3s in red blood cell membranes.

1. PSA (total and free) — prostate 2. CEA 3. AFP 4. CA 19-9

1. CA-125 — ovarian tumors 2. HE4 — clarification of the risk of malignant ovarian tumors 3. CEA (PEA) — gastrointestinal, breast, and lung cancer 4. CA 15-3 — breast cancer 5. AFP (alpha-fetoprotein) — liver, ovaries 6. CA 19-9 — pancreas, gastrointestinal tract

Screening for precancerous and cancerous changes in the cervix. Cervical Cytology

Diagnosis of Epstein-Barr virus, especially in adolescents

A COMPLETE SET OF TESTS THAT CHECK: This comprehensive profile measures a wide range of hormones and metabolic markers to support the diagnosis of Polycystic Ovary Syndrome (PCOS) and to assess related health risks. It includes: • Androgens such as testosterone, androstenedione, and DHEA-S to detect elevated male-type hormones commonly seen in PCOS. • Reproductive hormones including LH, FSH, prolactin, Anti-Müllerian Hormone (AMH), and 17-hydroxyprogesterone to evaluate ovulatory function and exclude other endocrine disorders. • Thyroid hormones (TSH) to identify thyroid dysfunction, which may mimic or worsen PCOS symptoms. • Cortisol to assess adrenal function and possible stress-related hormonal imbalance. • Glucose, insulin, and HbA1c to screen for insulin resistance and long-term glucose regulation. • Lipid profile to evaluate cardiovascular and metabolic risk factors often associated with PCOS. • Sex Hormone Binding Globulin (SHBG) to help determine the amount of free, biologically active testosterone. WHAT THIS TEST SUITE REVEALS: • Presence of hyperandrogenism, one of the core features of PCOS. • Ovulatory dysfunction, cycle irregularities, or hormonal imbalance. • Potential adrenal or pituitary abnormalities that may present with similar symptoms. • Degree of insulin resistance, impaired glucose tolerance, or early signs of diabetes. • Overall cardiometabolic risk through lipid and glucose markers. • Thyroid or other endocrine conditions that should be ruled out when assessing PCOS. • A clear, integrated picture of reproductive, metabolic, and adrenal health to support accurate diagnosis and personalised treatment planning.